Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027741 · ClinicalTrials.gov registry record · NA
Integrating Cancer Control Referrals and Navigators Into United Way 211 Missouri
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 4,762
- Enrollment target
NCT01027741: Completed NA study, sponsored by Washington University School of Medicine.
NCT01027741 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 4,762 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (239% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01027741, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,762 participants
- Enrollment target
Study Summary
The proposed study will: 1. estimate the prevalence of need for cancer screening and prevention in a population of 211 callers; 2. determine whether cancer communication interventions delivered through 211 can increase use of breast, cervical and colon cancer screening, HPV vaccination, smoking cessation and adoption of smoke free home policies; 3. determine how intensive an intervention is needed to bring about these changes; and 4. determine whether the effectiveness of these interventions is enhanced when callers' basic needs have been addressed. Connecting these systems - 211, clinical and community cancer control programs and navigation services - should benefit disadvantaged Americans. The proposed study will evaluate the effects of this approach to eliminating cancer disparities. We hypothesize that the proportion of 211 callers who obtain a needed cancer control service will: 1. differ significantly by study group as follows: N \> T \> P \> CONTROL; 2. vary significantly across study groups based on the intervention dose callers receive; and 3. vary significantly across study groups based on whether callers' original need was resolved, the extent of their basic needs, and their perception of life as manageable and predictable (i.e., sense of coherence). (Dissemination Aim): Determine costs to 211 and effects on quality of service by offering cancer control referrals.
Interventions
- BEHAVIORAL Phone Referral
- BEHAVIORAL Tailored Cancer Communication
- BEHAVIORAL Cancer Control Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,762 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01027741 record still lists
NCT01027741 is an interventional study that assigns participants to a tested intervention. Its 4,762 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (239% higher).
The record links to 0 conditions, and to 3 interventions - of which Phone Referral is the first listed.
NCT01027741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01027741 about?
NCT01027741 is a clinical study titled "Integrating Cancer Control Referrals and Navigators Into United Way 211 Missouri". The proposed study will: 1. estimate the prevalence of need for cancer screening and prevention in a population of 211 callers; 2. determine whether cancer communication interventions delivered through 211 can increase use of breast, cervical and colon cancer screening, HPV vaccination, smoking ces...
What is the current status of trial NCT01027741?
This trial is currently completed. It is a NA study. The enrollment target is 4,762 participants. The study started on 2009-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01027741?
The interventions under investigation include: Phone Referral (BEHAVIORAL), Tailored Cancer Communication (BEHAVIORAL), Cancer Control Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT01027741?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01027741's enrollment target sits among peer trials
4,762 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia